DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Ghiringhelli F, Menard C, Puig PE, Ladoie S, Roux S, Martin F, Solary E, Cesne A, Zitvogel L, Chauffert B.
Metronomic cyclophospamide regimen selectibvely depletes
CD4+CD25+ regulatory T cells and restores T and NK effector functions
in end stage cancer patients.
Cancer Immunology, Immunotherapy 2007; 56 (5) 641-648
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.